In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 309956-78-3, name is (R)-tert-Butyl piperidin-3-ylcarbamate, introducing its new discovery. Recommanded Product: (R)-tert-Butyl piperidin-3-ylcarbamate
PYRROLOPYRIMIDINE AND PURINE DERIVATIVES
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein Q, T, V, W, X, Y, Z, ring A, R1, R2, R3, R4, R5, R5a, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17 and m are defined herein. There novel pyrrolopyrimidine and purine derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. Additional embodiments relate to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions in the treatment of abnormal cell growth in mammals.
The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 309956-78-3 is helpful to your research. Recommanded Product: (R)-tert-Butyl piperidin-3-ylcarbamate
Reference£º
Piperidine – Wikipedia,
Piperidine | C5H13331N – PubChem